Skip to main content
Top
Published in: Current Pain and Headache Reports 7/2014

01-07-2014 | Uncommon Headache Syndromes (J Ailani, Section Editor)

New Daily Persistent Headache: An Update

Author: Todd D. Rozen

Published in: Current Pain and Headache Reports | Issue 7/2014

Login to get access

Abstract

New daily persistent headache is a primary headache disorder marked by a unique temporal profile which is daily from onset. For many sufferers this is their first ever headache. Very little is known about the pathogenesis of this condition. It might be a disorder of abnormal glial activation with persistent central nervous system inflammation and it may be a syndrome that occurs in individuals who have a history of cervical hypermobility. At present there is no known specific treatment and many patients go for years to decades without any improvement in their condition despite aggressive therapy. This article will present an up-to-date overview of new daily persistent headache on the topics of clinical presentation, treatment, diagnostic criteria, and presumed pathogenesis. It will also provide some of the authors own treatment suggestions based on recognized triggering events and some suggestions for future clinical trials.
Literature
1.
go back to reference Vanast WJ. New daily persistent headaches: definition of a benign syndrome. Headache. 1986;26:317. Vanast WJ. New daily persistent headaches: definition of a benign syndrome. Headache. 1986;26:317.
2.••
go back to reference Robbins MS, Grosberg BM, Napchan U, Crystal SC, Lipton RB. Clinical and prognostic subforms of new daily-persistent headache. Neurology. 2010;74:1358–64. Very nice manuscript describing clinical presentation, subforms, and treatment. PubMedCentralPubMedCrossRef Robbins MS, Grosberg BM, Napchan U, Crystal SC, Lipton RB. Clinical and prognostic subforms of new daily-persistent headache. Neurology. 2010;74:1358–64. Very nice manuscript describing clinical presentation, subforms, and treatment. PubMedCentralPubMedCrossRef
3.
go back to reference Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia. 2002;22:66–9.PubMedCrossRef Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia. 2002;22:66–9.PubMedCrossRef
4.
go back to reference Meineri P, Torre E, Rota E, Grossa E. New daily persistent headache: clinical and serological characteristics in a retrospective study. Neurol Sci. 2004;25 Suppl 3:S281–7.PubMedCrossRef Meineri P, Torre E, Rota E, Grossa E. New daily persistent headache: clinical and serological characteristics in a retrospective study. Neurol Sci. 2004;25 Suppl 3:S281–7.PubMedCrossRef
5.
go back to reference Takase Y, Nakano M, Tatsumi C, Matsuyama T. Clinical features, effectiveness of drug based treatment and prognosis of new daily persistent headache: 30 cases in Japan. Cephalalgia. 2004;24:955–9.PubMedCrossRef Takase Y, Nakano M, Tatsumi C, Matsuyama T. Clinical features, effectiveness of drug based treatment and prognosis of new daily persistent headache: 30 cases in Japan. Cephalalgia. 2004;24:955–9.PubMedCrossRef
6.••
go back to reference Prakash S, Saini S, Rana KR, Mahato P. Refining clinical features and therapeutic options of new daily persistent headache: a retrospective study of 63 patients in India. J Headache Pain. 2012;13:477–85. Very nice manuscript describing clinical presentation, and unique treatment paradigms. PubMedCentralPubMedCrossRef Prakash S, Saini S, Rana KR, Mahato P. Refining clinical features and therapeutic options of new daily persistent headache: a retrospective study of 63 patients in India. J Headache Pain. 2012;13:477–85. Very nice manuscript describing clinical presentation, and unique treatment paradigms. PubMedCentralPubMedCrossRef
7.
go back to reference Rozen TD, Swidan Rozen TD, Swidan S. Elevation of CSF tumor necrosis factor Alpha levels in NDPH and treatment refractory chronic daily migraine. Headache. 2006;46:897. Rozen TD, Swidan Rozen TD, Swidan S. Elevation of CSF tumor necrosis factor Alpha levels in NDPH and treatment refractory chronic daily migraine. Headache. 2006;46:897.
8.
go back to reference Durham PL. Calcitonin gene-related peptide (CGRP) and migraine. Headache. 2006;46 Suppl 1:3–8.CrossRef Durham PL. Calcitonin gene-related peptide (CGRP) and migraine. Headache. 2006;46 Suppl 1:3–8.CrossRef
9.
go back to reference Rozen TD, Roth JM, Denenberg N. Joint hypermobility as a predisposing factor for the development of new daily persistent headache. Headache. 2005;45:828–9. Rozen TD, Roth JM, Denenberg N. Joint hypermobility as a predisposing factor for the development of new daily persistent headache. Headache. 2005;45:828–9.
10.
go back to reference Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Headache Rep. 2003;2:155–61. Piovesan EJ, Kowacs PA, Oshinsky ML. Convergence of cervical and trigeminal sensory afferents. Curr Headache Rep. 2003;2:155–61.
11.
go back to reference Rozen TD. Doxycycline for treatment resistant new daily persistent headache. Neurology. 2008;70 Suppl 1:A348. Rozen TD. Doxycycline for treatment resistant new daily persistent headache. Neurology. 2008;70 Suppl 1:A348.
12.
go back to reference Marmura MJ, Passero FC, Young WB. Mexiletine for refractory chronic daily headache: a report of 9 cases. Headache. 2008;48:1506–10.PubMedCrossRef Marmura MJ, Passero FC, Young WB. Mexiletine for refractory chronic daily headache: a report of 9 cases. Headache. 2008;48:1506–10.PubMedCrossRef
13.
go back to reference Prakash S, Shah ND. Post-infectious new daily persistent headache may respond to intravenous methylprednisolone. J Headache Pain. 2010;1:59–66.CrossRef Prakash S, Shah ND. Post-infectious new daily persistent headache may respond to intravenous methylprednisolone. J Headache Pain. 2010;1:59–66.CrossRef
14.
go back to reference The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160. The International Classification of Headache Disorders, 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160.
15.••
go back to reference Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808. The new diagnostic criteria for NDPH recognized by the International Headache Society and the criteria that will be utilized for any future clinical trials.CrossRef Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808. The new diagnostic criteria for NDPH recognized by the International Headache Society and the criteria that will be utilized for any future clinical trials.CrossRef
16.
Metadata
Title
New Daily Persistent Headache: An Update
Author
Todd D. Rozen
Publication date
01-07-2014
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 7/2014
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-014-0431-6

Other articles of this Issue 7/2014

Current Pain and Headache Reports 7/2014 Go to the issue

Neuromodulation (M Gofeld, Section Editor)

Deep Brain and Motor Cortex Stimulation

Childhood and Adolescent Headache (S Evers, Section Editor)

Medication Overuse in Children and Adolescents

Imaging (A DaSilva, Section Editor)

Migraine and Inhibitory System – I Can't Hold It!

Trigeminal Autonomic Cephalalgias (M Matharu, Section Editor)

Role of Sphenopalatine Ganglion Stimulation in Cluster Headache